Ver mas grande
AKT1 antibody
FT-FNab00271
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC, IF, IP |
| Target | AKT1 |
| Research Area | Metabolism, Cardiovascular, Immunology, Developmental biology, Neuroscience, Stem Cells |
| Form | liquid |
| Recomended Dilution | WB: 1:1000-1:10000 |
| Type Clonality | monoclonal |
| Immunogen | v-akt murine thymoma viral oncogene homolog 1 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | RAC-alpha serine/threonine-protein kinase|Protein kinase B (PKB)|Protein kinase B alpha (PKB alpha)|Proto-oncogene c-Akt|RAC-PK-alpha|AKT1|PKB|RAC |
| Host | Mouse |
| UniProt ID | P31749 |
| Gene ID | 207 |
| Purification | Protein A+G purification |
| Clone Number | 8H0 |
| Iso type | IgG1 |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 56-62 kDa |
| Background | The serine-threonine protein kinase AKT1 is catalytically inactive in serum-starved primary and immortalized fibroblasts. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which t |
Más información
AKT antibody